89 related articles for article (PubMed ID: 25069535)
21. The effect of dipeptidyl peptidase IV on disease-associated microglia phenotypic transformation in epilepsy.
Zheng Z; Liang P; Hou B; Lu X; Ma Q; Yu X; Han S; Peng B; Chen T; Liu W; Yin J; He X
J Neuroinflammation; 2021 May; 18(1):112. PubMed ID: 33975617
[TBL] [Abstract][Full Text] [Related]
22. Degree of lung maturity determines the direction of the interleukin-1- induced effect on the expression of surfactant proteins.
Glumoff V; Väyrynen O; Kangas T; Hallman M
Am J Respir Cell Mol Biol; 2000 Mar; 22(3):280-8. PubMed ID: 10696064
[TBL] [Abstract][Full Text] [Related]
23. Design and synthesis of 4-(2,4,5-trifluorophenyl)butane-1,3-diamines as dipeptidyl peptidase IV inhibitors.
Zhu L; Li Y; Qiu L; Su M; Wang X; Xia C; Qu Y; Li J; Li J; Xiong B; Shen J
ChemMedChem; 2013 Jul; 8(7):1104-16. PubMed ID: 23671024
[TBL] [Abstract][Full Text] [Related]
24. Overexpression of surfactant protein SP-A, SP-B, and SP-C mRNA in rat lungs with lipopolysaccharide-induced injury.
Sugahara K; Iyama K; Sano K; Kuroki Y; Akino T; Matsumoto M
Lab Invest; 1996 Jan; 74(1):209-20. PubMed ID: 8569184
[TBL] [Abstract][Full Text] [Related]
25. Effects of maternal nicotine exposure on lung surfactant system in rats.
Chen CM; Wang LF; Yeh TF
Pediatr Pulmonol; 2005 Feb; 39(2):97-102. PubMed ID: 15532091
[TBL] [Abstract][Full Text] [Related]
26. Synthesis, SAR, and atropisomerism of imidazolopyrimidine DPP4 inhibitors.
O'Connor SP; Wang Y; Simpkins LM; Brigance RP; Meng W; Wang A; Kirby MS; Weigelt CA; Hamann LG
Bioorg Med Chem Lett; 2010 Nov; 20(21):6273-6. PubMed ID: 20833042
[TBL] [Abstract][Full Text] [Related]
27. Role of dipeptidyl peptidase IV (DPP4) in the development of dyslipidemia: DPP4 contributes to the steroid metabolism pathway.
Sato Y; Koshioka S; Kirino Y; Kamimoto T; Kawazoe K; Abe S; Minakuchi K; Nakahori Y
Life Sci; 2011 Jan; 88(1-2):43-9. PubMed ID: 21047519
[TBL] [Abstract][Full Text] [Related]
28. The combination of metformin and a dipeptidyl peptidase IV inhibitor prevents 5-fluorouracil-induced reduction of small intestine weight.
Yamazaki K; Yasuda N; Inoue T; Nagakura T; Kira K; Saeki T; Tanaka I
Eur J Pharmacol; 2004 Mar; 488(1-3):213-8. PubMed ID: 15044053
[TBL] [Abstract][Full Text] [Related]
29. Stimulation of intestinal growth and function with DPP4 inhibition in a mouse short bowel syndrome model.
Sueyoshi R; Woods Ignatoski KM; Okawada M; Hartmann B; Holst J; Teitelbaum DH
Am J Physiol Gastrointest Liver Physiol; 2014 Aug; 307(4):G410-9. PubMed ID: 24970775
[TBL] [Abstract][Full Text] [Related]
30. Surfactant proteins A and D increase in response to intratracheal lipopolysaccharide.
McIntosh JC; Swyers AH; Fisher JH; Wright JR
Am J Respir Cell Mol Biol; 1996 Oct; 15(4):509-19. PubMed ID: 8879185
[TBL] [Abstract][Full Text] [Related]
31. Increased surfactant protein a and d expression in acute ovalbumin-induced allergic airway inflammation in brown norway rats.
Schmiedl A; Lührmann A; Pabst R; Koslowski R
Int Arch Allergy Immunol; 2009; 148(2):118-26. PubMed ID: 18802356
[TBL] [Abstract][Full Text] [Related]
32. Glucocorticoid regulation of surfactant-associated proteins in rabbit fetal lung in vivo.
Durham PL; Wohlford-Lenane CL; Snyder JM
Anat Rec; 1993 Nov; 237(3):365-77. PubMed ID: 8291690
[TBL] [Abstract][Full Text] [Related]
33. The combined effects of insulin and cortisol on surfactant protein mRNA levels.
Dekowski SA; Snyder JM
Pediatr Res; 1995 Oct; 38(4):513-21. PubMed ID: 8559602
[TBL] [Abstract][Full Text] [Related]
34. 7-Oxopyrrolopyridine-derived DPP4 inhibitors-mitigation of CYP and hERG liabilities via introduction of polar functionalities in the active site.
Wang W; Devasthale P; Wang A; Harrity T; Egan D; Morgan N; Cap M; Fura A; Klei HE; Kish K; Weigelt C; Sun L; Levesque P; Li YX; Zahler R; Kirby MS; Hamann LG
Bioorg Med Chem Lett; 2011 Nov; 21(22):6646-51. PubMed ID: 21996520
[TBL] [Abstract][Full Text] [Related]
35. Dipeptidyl peptidase IV (DPP4)-deficiency attenuates diet-induced obesity in rats: possible implications for the hypothalamic neuropeptidergic system.
Stephan M; Radicke A; Leutloff S; Schmiedl A; Pabst R; von Hörsten S; Dettmer S; Lotz J; Nave H
Behav Brain Res; 2011 Jan; 216(2):712-8. PubMed ID: 20887754
[TBL] [Abstract][Full Text] [Related]
36. Identification and characterization of dipeptidyl peptidase IV enzyme activity in the American crocodile (Crocodylus acutus).
Merchant M; Mead S; McAdon C; McFatter J; Wasilewski J
Vet Immunol Immunopathol; 2010 Jul; 136(1-2):28-33. PubMed ID: 20227771
[TBL] [Abstract][Full Text] [Related]
37. [Role of Dipeptidyl peptidase inhibitors in lung ischemia-reperfusion injury].
Lu ZL; Gao ML; Deng Y; Liu BH; Li N; Geng Q
Zhonghua Jie He He Hu Xi Za Zhi; 2022 Dec; 45(12):1266-1270. PubMed ID: 36480859
[TBL] [Abstract][Full Text] [Related]
38. Cell-specific modulation of surfactant proteins by ambroxol treatment.
Seifart C; Clostermann U; Seifart U; Müller B; Vogelmeier C; von Wichert P; Fehrenbach H
Toxicol Appl Pharmacol; 2005 Feb; 203(1):27-35. PubMed ID: 15694461
[TBL] [Abstract][Full Text] [Related]
39. Decreased surfactant protein-B expression and surfactant dysfunction in a murine model of acute lung injury.
Ingenito EP; Mora R; Cullivan M; Marzan Y; Haley K; Mark L; Sonna LA
Am J Respir Cell Mol Biol; 2001 Jul; 25(1):35-44. PubMed ID: 11472973
[TBL] [Abstract][Full Text] [Related]
40. Elevated expression of surfactant proteins in newborn rats during adaptation to hyperoxia.
White CW; Greene KE; Allen CB; Shannon JM
Am J Respir Cell Mol Biol; 2001 Jul; 25(1):51-9. PubMed ID: 11472975
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
